A 42-year-old female with von Willebrand's disease was managed with desmopressin and tranexamic acid to aid haemostasis following a vaginal hysterectomy. Severe acute hyponatraemia (134 to 108 mmol/l) developed over two days, culminating in a generalized tonic-clonic seizure and cerebral oedema. Fluid restriction, cessation of desmopressin and hypertonic saline administration led to a full recovery. Desmopressin is known to reduce free water elimination and produce hyponatraemia, but its extent and rate of development in this patient was surprising. Close monitoring of serum sodium and fluid balance is recommended in these patients.
Desmopressin has been used for over 20 years to improve the haemostasis of patients with von Willebrand's disease. Its antidiuretic action reduces free water clearance and tends to produce hyponatraemia, but short perioperative courses rarely cause any complication [1] [2] [3] . We report a patient who rapidly developed severe symptomatic hyponatraemia following desmopressin administration.
CASE REPORT
A 42-year-old female with a history of type 1 von Willebrand's disease presented for an elective vaginal hysterectomy. Her only significant history was hyperthyroidism, but she was currently euthyroid and on no medications. Her preoperative sodium concentration was 134 mmol/l, renal function and all other routine investigations were normal. Previous surgery with a preoperative desmopressin infusion of 0.3 µg/kg had been uneventful.
She received an infusion of desmopressin 0.3 µg/kg one hour preoperatively and was commenced on tranexamic acid 1.0 g tds. Her procedure was performed under general anaesthesia and resulted in minimal blood loss. No pethidine or non-steroidal anti-inflammatory drugs were administered.
Three further doses of desmopressin 0.3 µg/kg were infused over the next 48 hours. Intravenous fluids consisted of three litres of Ringer's lactate over the first 24 hours, after which she was allowed a normal diet. The extent of her oral fluid intake over this time is unknown. At 48 hours postoperatively, she suffered a generalized tonic-clonic seizure which terminated spontaneously, following which she remained confused and irritable. Serum sodium concentration at this time was 108 mmol/l. A CT scan of the head revealed no haemorrhages and open basal cisterns, but moderate cerebral oedema was demonstrated.
In view of her acute, severe hyponatraemia, 3% sodium chloride was infused at 100 ml/h which raised her serum sodium to 130 mmol/l over the next 24 hours. Desmopressin and tranexamic acid were ceased. Her neurological state improved in parallel with her electrolyte status and she was discharged with no neurological deficit on day six post-operation.
DISCUSSION
Desmopressin has been used to prevent and treat bleeding during surgery in patients with von Willebrand's disease since 1974. The recommended dose of desmopressin for surgical prophylaxis is 0.3 µg/kg given intravenously or subcutaneously at 12 or 24 hour intervals 1, 4 . A shortening of the prolonged activated partial thromboplastin time and bleeding time occurs. This is thought to be a result of increases in factor VIII and von Willebrand factor concentrations 1, 4, 5 . Desmopressin acts selectively on V2 receptors, one of three identified vasopressin receptor types 1 . These are G protein-coupled receptors found throughout the body. The main function of V2 receptors is the insertion of protein water channels (aquaporins) in membranes 6 . The release of factor VIII and von Willebrand factor after administration of desmopressin to anephric patients suggests that extra-renal V2 receptors mediate this action 7, 8 .
Desmopressin is associated with relatively few sideeffects. Facial flushing, a feeling of warmth, tachycardia and a 10 to 20% decrease in diastolic blood pressure are common, yet relatively minor effects 4 . Through its action on the renal V2 receptors, desmopressin induces the deposition of the protein water channel aquaporin-2 in the luminal membranes of collecting duct cells 1 . This increases the permeability of the distal nephron to water, concentrating the urine and retaining water in excess of solute 6 . In this way desmopressin may cause hyponatraemia and water intoxication. In the presence of ongoing fluid intake (isotonic in the first 24 hours, but probably hypotonic in the second 24 hours postoperatively in this case) a dilutional hyponatraemia results.
The risk of water intoxication may be increased in postoperative patients, in whom the stress response to surgery, via the release of endogenous vasopressin, aldosterone and cortisol, exacerbates water retention along with renal retention of sodium and excretion of potassium.
Vasopressin analogues have been shown to have a pro-convulsant effect in experimental animals 9 . Seizures induced by pilocarpine are potentiated by some V2 receptor agonists, but desmopressin was shown to have no such activity. A direct aetiological role for desmopressin in the seizure in this case is therefore unlikely.
Published case reports of hyponatraemic seizures associated with desmopressin treatment fall into two sub-groups, those being treated for enuresis and those receiving desmopressin for perioperative haemostasis [10] [11] [12] [13] [14] [15] [16] [17] [18] . Hyponatraemia is more common in those being treated with intranasal desmopressin for primary nocturnal enuresis. The majority of such cases occur in children, however two reports involved adults 10, 11 . These cases were associated with longer-term desmopressin use than is seen in the perioperative patient.
Fifteen cases of hyponatraemia associated with desmopressin use for perioperative haemostasis were reviewed [15] [16] [17] [18] . Three of these involved adults, who received three or four infusions of 0.3 to 0.5 µg/kg. Only one case involved hypotonic intravenous fluids postoperatively. Subsequent serum sodium levels of 124, 118 and 121 mmol/l were associated with symptoms of headache, confusion and agitation, and lethargy respectively.
The significance of the case we have reported is the severity and rapid onset of the hyponatraemia following appropriate desmopressin administration and the absence of other risk factors for exaggerated water retention. The dose of 0.3 µg/kg and 24 hour dosing intervals is in keeping with current practice. Intraoperative and postoperative fluids were isotonic, but the extent of the patient's water intake on the second postoperative day is unknown. We are unable to identify why in this case there was such a rapid onset of a degree of hyponatraemia far more severe than ever described in association with desmopressin usage. The clinical sequelae of seizure and demonstrable cerebral oedema within two days of surgery illustrate the importance of clinical and biochemical monitoring of all patients.
In the absence of detailed knowledge of the true frequency of hyponatraemia secondary to desmopressin administration, caution should be exercised in these cases. Previously reported cases support our suspicion that multiple doses of desmopressin along with intravenous hydration followed by unrestricted oral hydration were responsible for such a severe dilutional hyponatraemia. The rapid onset of the hyponatraemia would indicate that clinical vigilance, daily serum sodium estimations and strict fluid balance are appropriate for the duration of the therapy in these patients.
